These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11342425

  • 1. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway.
    Dror Y, Freedman MH.
    Blood; 2001 May 15; 97(10):3011-6. PubMed ID: 11342425
    [Abstract] [Full Text] [Related]

  • 2. Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy.
    Iijima N, Miyamura K, Itou T, Tanimoto M, Sobue R, Saito H.
    Blood; 1997 Dec 15; 90(12):4901-9. PubMed ID: 9389707
    [Abstract] [Full Text] [Related]

  • 3. Assessment of bone marrow stem cell reserve and function and stromal cell function in patients with autoimmune cytopenias.
    Papadaki HA, Gibson FM, Rizzo S, Gordon-Smith EC, Marsh JC.
    Blood; 2000 Nov 01; 96(9):3272-5. PubMed ID: 11050013
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis.
    Josefsen D, Myklebust JH, Lynch DH, Stokke T, Blomhoff HK, Smeland EB.
    Exp Hematol; 1999 Sep 01; 27(9):1451-9. PubMed ID: 10480436
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.
    Feuring-Buske M, Hogge DE.
    Blood; 2001 Jun 15; 97(12):3882-9. PubMed ID: 11389030
    [Abstract] [Full Text] [Related]

  • 10. CD38 ligation inhibits normal and leukemic myelopoiesis.
    Todisco E, Suzuki T, Srivannaboon K, Coustan-Smith E, Raimondi SC, Behm FG, Kitanaka A, Campana D.
    Blood; 2000 Jan 15; 95(2):535-42. PubMed ID: 10627459
    [Abstract] [Full Text] [Related]

  • 11. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
    Haase D, Feuring-Buske M, Schäfer C, Schoch C, Troff C, Gahn B, Hiddemann W, Wörmann B.
    Leukemia; 1997 May 15; 11(5):674-9. PubMed ID: 9180291
    [Abstract] [Full Text] [Related]

  • 12. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.
    Kollet O, Spiegel A, Peled A, Petit I, Byk T, Hershkoviz R, Guetta E, Barkai G, Nagler A, Lapidot T.
    Blood; 2001 May 15; 97(10):3283-91. PubMed ID: 11342460
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells.
    Dybedal I, Bryder D, Fossum A, Rusten LS, Jacobsen SE.
    Blood; 2001 Sep 15; 98(6):1782-91. PubMed ID: 11535512
    [Abstract] [Full Text] [Related]

  • 15. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
    Rusten LS, Jacobsen SE, Kaalhus O, Veiby OP, Funderud S, Smeland EB.
    Blood; 1994 Sep 01; 84(5):1473-81. PubMed ID: 7520773
    [Abstract] [Full Text] [Related]

  • 16. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study.
    Dror Y, Durie P, Ginzberg H, Herman R, Banerjee A, Champagne M, Shannon K, Malkin D, Freedman MH.
    Exp Hematol; 2002 Jul 01; 30(7):659-69. PubMed ID: 12135662
    [Abstract] [Full Text] [Related]

  • 17. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
    Robinson SN, Freedman AS, Neuberg DS, Nadler LM, Mauch PM.
    Exp Hematol; 2000 Dec 01; 28(12):1325-33. PubMed ID: 11146154
    [Abstract] [Full Text] [Related]

  • 18. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development.
    Waller EK, Huang S, Terstappen L.
    Blood; 1995 Jul 15; 86(2):710-8. PubMed ID: 7541673
    [Abstract] [Full Text] [Related]

  • 19. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
    Costello RT, Mallet F, Gaugler B, Sainty D, Arnoulet C, Gastaut JA, Olive D.
    Cancer Res; 2000 Aug 15; 60(16):4403-11. PubMed ID: 10969785
    [Abstract] [Full Text] [Related]

  • 20. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence.
    Harvey K, Higgins N, Akard L, Chang Q, Jansen J, Thompson J, Dugan M, Rizzo MT, English D.
    J Hematother; 1997 Jun 15; 6(3):243-52. PubMed ID: 9234179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.